Industry News
Gene That Signals "Stop!" To Skin Cancer Found
Nov 15, 2011
Scientists have found a gene whose absence may be an important driver for a common form of skin cancer known as squamous cell cancer (SCC), because its presence signals "Stop!" to cell proliferation. The international team found the gene, called Grhl3, is also virtually absent in SCC that arises in other tissues, including head and neck cancers, that often have a poor prognosis... Read More
Bonded Asbestos No Longer Considered Safe, Say Experts
Nov 15, 2011
The rise in the number of natural disaster means we cannot consider bonded asbestos as safe anymore, cancer experts in Perth said in the Clinical Oncological Society of Australia's Annual Scientific Meeting... Read More
Global Prostate Cancer Risk Linked To Contraceptive Pill Usage
Nov 15, 2011
According to an investigation published in BMJ Open, the use of the contraceptive pill is linked with an increased risk of prostate cancer worldwide. In developed countries prostate cancer is the most prevalent form of cancer among males and the use of the contraceptive pill has significantly increased over the past 4 decades... Read More
Colorectal Cancer-Screening - CT Colonography Usage Growing Much Faster Than Colonoscopy
Nov 15, 2011
A study published Online First in The Lancet Oncology shows that CT colonography as an additional primary colorectal cancer-screening test could result in a significantly higher participation in screening programs than conventional colonoscopy. Colorectal cancer remains the second leading cause of cancer deaths in Europe... Read More
Oral Contraceptive Use Tied To Prostate Cancer
Nov 15, 2011
There is a significant link between use of oral contraceptives or birth control pills and the incidence of prostate cancer, said researchers who set out to investigate the suggestion that byproducts of these drugs get into the environment, for instance the water supply, and lead to an increase in low level estrogen exposure in affected populations... Read More
Certain Side Effects In BRAF Mutation-Positive Melanoma May Be Prevented By New Approaches
Nov 15, 2011
Findings from preclinical studies in a skin cancer model showed that next-generation BRAF inhibitors used alone, or first-generation BRAF inhibitors used in combination with an epidermal growth factor receptor inhibitor, may have the potential to prevent drug-induced skin lesions in BRAF mutation-positive patients treated for melanoma... Read More
A More Effective Clot Buster? Gelatin-Based Nanoparticle Treatment
Nov 15, 2011
A targeted, nanoparticle gelatin-based clot-busting treatment dissolved significantly more blood clots than a currently used drug in an animal study of acute coronary syndrome presented at the American Heart Association's Scientific Sessions 2011. The new drug-delivery system used gelatin to deactivate the clot-busting drug tissue plasminogen activator, or tPA, to treat acute coronary syndrome... Read More
Canadian Researchers Find Potential New Leukemia Treatment With Old Antibiotic Drug
Nov 15, 2011
Clinician-scientists in the Princess Margaret Cancer Program have found a promising approach to treating leukemia, using an old drug in a new way. The proof-of-concept research published today in Cancer Cell (10.1016/j.ccr.2011.10.015) describes how the Canadian team discovered that the antibiotic tigecycline targets and destroys leukemia stem cells by cutting off the cell's energy production... Read More
Potential Treatment For Tumors Resistant To VEGF Therapy Offered By Novel Monoclonal Antibody
Nov 15, 2011
Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancer cells... Read More
Antifolates Show Promise Against Non-Small Cell Lung Cancer Subtype
Nov 15, 2011
Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer cell lines and patients... Read More
Previous Page Next Page